Americans Can’t Buy the Top-Notch Sunscreen That Europeans Have Been Using for Years

The best sunburn protections are blocked by a federal backlog, but Congress is pushing legislation it says will clear the way.

National Journal
Sophie Novack
See more stories about...
Sophie Novack
April 7, 2014, 10:04 a.m.

Sun­screens that have been avail­able in Europe and oth­er for­eign mar­kets for years re­main banned from U.S. stores be­cause of a back­log in the fed­er­al bur­eau­cracy.

The in­gredi­ents that make the sun­screen su­per­i­or have been await­ing ap­prov­al — or any sort of de­cision — from the Food and Drug Ad­min­is­tra­tion for at least 12 years. There are cur­rently eight such in­gredi­ents stuck in the sys­tem.

Without ac­cess to the in­gredi­ents, con­sumers may be blocked from buy­ing the sun­screens that provide the most ef­fect­ive pro­tec­tions against harm­ful rays.

Con­gress has a plan to break the 12-year back­log: The House En­ergy and Com­merce Com­mit­tee on Monday is look­ing at le­gis­la­tion that would ex­ped­ite the FDA’s ap­prov­al pro­cess for sun­screen in­gredi­ents. Should the pan­el ap­prov­al the meas­ure, it would put the bill one step closer to pas­sage.

A com­pan­ion ver­sion of the House bill is pending with the Sen­ate’s Health Com­mit­tee.

The le­gis­la­tion aims to im­prove on the fed­er­al gov­ern­ment’s latest at­tempt to make it­self more nimble in keep­ing up with sun­block tech­no­logy: a 2002 pro­ced­ur­al change from the FDA that the agency hoped would speed up its ap­prov­al pro­cess.

But without a single in­gredi­ent be­ing ap­proved since then, ad­voc­ates say it’s time for an­oth­er try.

“FDA’s goal was to cre­ate a more stream­lined pro­cess; it just didn’t work out that way,” says a staff mem­ber of the Pub­lic Ac­cess to Sun­Screens Co­ali­tion. “Every­one — melan­oma re­search­ers, the com­munity, man­u­fac­tur­ers, pa­tients, even the FDA — every­one agrees the cur­rent situ­ation is not work­ing. When you com­bine that with the in­creas­ing rates of skin can­cer, it’s a ser­i­ous pub­lic-health con­cern.”

At stake is more than sun­burns: Skin can­cer is the most com­mon form of can­cer in the United States. more than 2 mil­lion cases are dia­gnosed each year, many of which could be pre­ven­ted by pro­tect­ing the skin from sun ex­pos­ure, ac­cord­ing to the Amer­ic­an Can­cer So­ci­ety.

Con­gres­sion­al ad­voc­ates hope they can im­prove the FDA’s ex­ist­ing pro­ced­ure without upend­ing the en­tire sys­tem.

Un­der cur­rent law, if an in­gredi­ent is on the mar­ket in an­oth­er coun­try for five years, it may go through a pro­cess to be de­term­ined eli­gible by the FDA. An ad­vis­ory com­mit­tee of ex­perts then weighs in on the safety and ef­fect­ive­ness of the product, and the agency makes the fi­nal de­term­in­a­tion as to wheth­er it is ap­proved.

The Sun­screen In­nov­a­tion Act makes two primary changes to this pro­cess. First, it would in­sti­tute an eight-month dead­line for the FDA to make a de­cision, re­pla­cing a cur­rent re­view pro­cess that lacks a man­dat­ory end date. Second, the bill would no longer re­quire the FDA to is­sue a reg­u­la­tion every time it wants to ap­prove an in­gredi­ent.

The FDA de­clined to com­ment on the bill, but a spokes­per­son said the agency has “pri­or­it­ized re­view­ing the safety and ef­fect­ive­ness of ad­di­tion­al sun­screen in­gredi­ents as quickly as pos­sible giv­en the agency’s re­sources.”

This frus­tra­tion has boiled over to Cap­it­ol Hill, with match­ing House and Sen­ate bills to ad­dress the prob­lem. The House ver­sion be­ing con­sidered Monday was in­tro­duced by Re­pub­lic­an Ed Whit­field and Demo­crat John Din­gell. The Sen­ate ver­sion came from Demo­crat Jack Reed and Re­pub­lic­an Johnny Isak­son.

With back­ing from both parties, ad­voc­ates are cau­tiously op­tim­ist­ic about the bills be­com­ing law, but they re­cog­nize that bi­par­tis­an sup­port is no guar­an­tee of pas­sage — par­tic­u­larly in the cur­rent grid­locked en­vir­on­ment.

“Try­ing to pre­dict what Con­gress is go­ing to do is kind of like hav­ing a per­fect March Mad­ness brack­et,” the sun­screens co­ali­tion staff mem­ber said. “But I will say there has been tre­mend­ous bi­par­tis­an, bicam­er­al sup­port.”

What We're Following See More »
STAFF PICKS
After Wikileaks Hack, DNC Staffers Stared Using ‘Snowden-Approved’ App
5 hours ago
WHY WE CARE

The Signal app is fast becoming the new favorite among those who are obsessed with the security and untraceabilty of their messaging. Just ask the Democratic National Committee. Or Edward Snowden. As Vanity Fair reports, before news ever broke that the DNC's servers had been hacked, word went out among the organization that the word "Trump" should never be used in their emails, lest it attract hackers' attention. Not long after, all Trump-related messages, especially disparaging ones, would need to be encrypted via the Snowden-approved Signal.

Source:
WARRING FACTIONS?
Freedom Caucus Members May Bolt the RSC
7 hours ago
WHY WE CARE

The Republican Study Committee may lose several members of the House Freedom Caucus next year, "potentially creating a split between two influential groups of House conservatives." The Freedom Caucus was founded at the inception of the current Congress by members who felt that the conservative RSC had gotten too cozy with leadership, "and its roughly 40 members have long clashed with the RSC over what tactics to use when pushing for conservative legislation." As many as 20 members may not join the RSC for the new Congress next year.

Source:
SOME THERAPIES ALREADY IN TRIALS
FDA Approves Emergency Zika Test
9 hours ago
THE LATEST

"The U.S. Food and Drug Administration on Monday issued emergency authorization for a Zika diagnostics test from Swiss drugmaker Roche, skirting normal approval channels as the regulator moves to fight the disease's spread." Meanwhile, the Wall Street Journal reports that a new study in Nature identifies "about a dozen substances" that could "suppress the pathogen's replication." Some of them are already in clinical trials.

Source:
MONEY HAS BEEN PAID BACK
Medicare Advantage Plans Overcharged Government
9 hours ago
THE DETAILS

According to 37 newly released audits, "some private Medicare plans overcharged the government for the majority of elderly patients they treated." A number of Medicare Advantage plans overstated "the severity of medical conditions like diabetes and depression." The money has since been paid back, though some plans are appealing the federal audits.

Source:
DESPITE CONSERVATIVE OBJECTIONS
Omnibus Spending Bill Likely Getting a Lame-Duck Vote
10 hours ago
WHY WE CARE

"GOP leaders and House Democrats are already laying the groundwork for a short-term continuing resolution" on the budget this fall "that will set up a vote on a catch-all spending bill right before the holidays." As usual, however, the House Freedom Caucus may throw a wrench in Speaker Paul Ryan's gears. The conservative bloc doesn't appear willing to accept any CR that doesn't fund the government into 2017.

Source:
×